INSIGHTS ON QUALITY ASSURANCE
-
Designing An Inspector Rotation That Holds Up
Establish robust visual inspection rotations by separating planned dates from compliance expirations and using standardized templates to prevent scheduling bottlenecks.
-
Ultimate X-Ray Shootout
Discover how advanced X-ray inspection systems balance contaminant sensitivity and cost, accurately detecting minute glass and metal fragments within high-density packaging lines.
-
Site Expansion Success Blueprint
Discover how a global pharmaceutical manufacturer unified six sites under one asset management strategy, improving compliance and scalability to help teams plan, prepare data, and expand confidently.
-
Minimizing Particulate Risk
While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.
-
What Your Biological Indicator Strategy Might Be Missing7/28/2026
While biological indicators have long been the industry standard for evaluating bio-decontamination cycles, faster, cheaper, and quantifiable contamination detection technologies are emerging.
-
Looking Back At USP <86>: Key Changes And Their Impact On Biological Reactivity Testing7/16/2026
USP <86> introduces validated recombinant alternatives for endotoxin testing, supporting animal-free QC. Learn key validation, comparability, and regulatory considerations.
-
The Golden Age Of Life Sciences Innovation Needs Smarter Data2/6/2026
Manufacturers face growing pressure to support personalized therapies with flexible and sustainable operations. See how success now hinges on managing context-rich data to strengthen decision-making.
-
Leverage Apps To Reduce Line Changeover Time From 14 Days To 36/26/2025
A global biopharma leader modernized its complex equipment changeover process using an innovative platform to achieve faster execution, fewer errors, and greater visibility through digitized, validatable SOPs.
-
Overcoming Volume And Viscosity Barriers In Biologic Formulations7/2/2026
Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.
QUALITY ASSURANCE SOLUTIONS
-
This manufacturing platform optimizes fields such as digitizing work processes, quality management, and digital transformation in pharmaceutical companies. Looking to digitize? Read more here.
-
Unify your compliance and data ecosystem on a single platform. Automate training, manage document changes, and accelerate software validation seamlessly.
-
Particulate control starts with practical decisions. Learn how material selection, acceptance criteria, and operator handling practices can help reduce contamination risk and support stronger quality.
-
Quality control is a critical component for ensuring safety, efficacy, and consistency in the development and production of biologics. This comprehensive list of strategies, techniques, workflows, and best-in-class products for developing biopharmaceuticals can help you navigate the complexities of biologics and simplify the manufacturing process. Improve your quality control procedures and optimize your biologics production process with tools and expertise relied upon by researchers worldwide.
-
V15 Label Inspection 360° System
Compact, efficient, and reliable. This space-saving solution detects label data and quality defects on round products. Six image sensors are enclosed in a compact design that can easily be installed over existing conveyors. The V15 can be extended with top and bottom cameras.
100% Automated Label Inspection 360°
This cost-effective vision system is ideally suited to replace manual spot checks with 100% automated label inspection control for round products.
Compliance Support
The V15 supports consumer safety in offering documented label inspection in line with industry guidelines such as IFS and BRCGS.
Reduce Waste and Prevent Recalls
The V15 verifies labels to detect and reliably sort non-conforming products to avoid costly recalls due to false or missing declarations.